Showing results (801-810 of 956) with videos related to
Sort By:
Pageof 96
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|January 16, 2025
FilmArray® effectively detects all clades of F41 but encounters challenges with other adenovirus speciesShun Ito, Chika Takano, Sheikh Ariful Hoque, et al.Scientific Reports|October 12, 2017
Nuclear factor (erythroid derived 2)-like 2 activation increases exercise endurance capacity via redox modulation in skeletal musclesSechang Oh, Shoichi Komine, Eiji Warabi, et al.Clinical and Experimental Immunology|November 18, 2003
Significant elevation of serum levels of eotaxin-3/CCL26, but not of eotaxin-2/CCL24, in patients with atopic dermatitis: serum eotaxin-3/CCL26 levels reflect the disease activity of atopic dermatitisS Kagami, T Kakinuma, H Saeki, et al.Journal of Medical Virology|September 12, 2024
Epidemiology and molecular evolution of GI.1 sapovirus in the recent eraSheikh A Hoque, Yuki Akari, Pattara Khamrin, et al.The Plant Journal : for Cell and Molecular Biology|May 29, 2023
A very long chain fatty acid responsive transcription factor, MYB93, regulates lateral root development in ArabidopsisYuta Uemura, Saori Kimura, Tomomichi Ohta, et al.International Journal of Molecular Sciences|February 13, 2025
Oxidative Stress Enhances Rubella Virus Infection in Immortalized Human First-Trimester TrophoblastsQuang Duy Trinh, Kazuhide Takada, Ngan Thi Kim Pham, et al.Frontiers in Microbiology|July 25, 2022
Enhancement of Rubella Virus Infection in Immortalized Human First-Trimester Trophoblasts Under Low-Glucose Stress ConditionsQuang Duy Trinh, Kazuhide Takada, Ngan Thi Kim Pham, et al.The Journal of Experimental Medicine|July 2, 2003
The Runx1 transcription factor inhibits the differentiation of naive CD4+ T cells into the Th2 lineage by repressing GATA3 expressionOkiru Komine, Keitaro Hayashi, Waka Natsume, et al.European Journal of Immunology|July 21, 2006
CCL17 transgenic mice show an enhanced Th2-type response to both allergic and non-allergic stimuliYuichiro Tsunemi, Hidehisa Saeki, Koichiro Nakamura, et al.Plos One|May 11, 2017
Efficacy and safety of gemcitabine plus docetaxel in Japanese patients with unresectable or recurrent bone and soft tissue sarcoma: Results from a single-institutional analysisMasanobu Takahashi, Keigo Komine, Hiroo Imai, et al.Pageof 96